These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28243416)

  • 1. Developing a national formulary based on a unified payment system in Iran.
    Ahmadi M; Amraei M; Samadbeik M
    Electron Physician; 2017 Jan; 9(1):3623-3629. PubMed ID: 28243416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing drug formularies for the "National Medical Holding" JSC.
    Akhmadyar NS; Khairulin BE; Amangeldy-Kyzy S; Ospanov MA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S51-2. PubMed ID: 26639709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive List of Items to be Included on a Pediatric Drug Monograph.
    Kelly LE; Ito S; Woods D; Nunn AJ; Taketomo C; de Hoog M; Offringa M
    J Pediatr Pharmacol Ther; 2017; 22(1):48-59. PubMed ID: 28337081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysis.
    Claus B; Commeyne S; Van de Casteele M; Rottey S
    Int J Clin Pharm; 2022 Jun; 44(3):769-774. PubMed ID: 35199288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'Ivoire.
    Diaby V; Lachaine J
    Appl Health Econ Health Policy; 2011 Nov; 9(6):389-402. PubMed ID: 22017499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitude and opinion towards essential medicine formulary.
    Sharma S; Kh R; Chaudhury RR
    Indian J Pharmacol; 2010 Jun; 42(3):150-2. PubMed ID: 20871765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.
    Alabbadi I; Crealey G; Scott M; Baird S; Trouton T; Mairs J; McElnay J
    Clin Drug Investig; 2006; 26(9):485-94. PubMed ID: 17163281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting the Acceptance Criteria of Medicines in the Reimbursement List of Public Health Insurance of Iran, Using the "Borda" Method: a Pilot Study.
    Viyanchi A; Rasekh HR; Rajabzadeh Ghatari A; SafiKhani HR
    Iran J Pharm Res; 2015; 14(4):1305-16. PubMed ID: 26664402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
    J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran.
    Safari H; Arab M; Rashidian A; Kebriaee-Zadeh A; Abolghasem Gorji H
    Iran J Pharm Res; 2018; 17(4):1593-1603. PubMed ID: 30568715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Investigation of Prescription Indicators and Trends Among General Practitioners and Specialists From 2005 to 2015 in Kerman, Iran.
    Masoud A; Noori Hekmat S; Dehnavieh R; Haj-Akbari N; Poursheikhali A; Abdi Z
    Int J Health Policy Manag; 2018 Sep; 7(9):818-827. PubMed ID: 30316230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Providing safe medicines for children in Nigeria: The impediments and remedies.
    Oshikoya KA; Senbanjo IO
    Ann Afr Med; 2010; 9(4):203-12. PubMed ID: 20935418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran.
    Yusefzadeh H; Rezapour A; Lotfi F; Ebadifard Azar F; Nabilo B; Abolghasem Gorji H; Hadian M; Shahidisadeghi N; Karami A
    Glob J Health Sci; 2015 Apr; 7(6):295-307. PubMed ID: 26153184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries.
    Barnieh L; Manns B; Harris A; Blom M; Donaldson C; Klarenbach S; Husereau D; Lorenzetti D; Clement F
    Value Health; 2014; 17(1):98-108. PubMed ID: 24438723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a Model for National Health Information Governance Program in Iran.
    Rouzbahani F; Asadi F; Rabiei R; Moghaddasi H; Emami H
    J Med Life; 2020; 13(4):510-516. PubMed ID: 33456599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Practical Application of a Multiple-Criteria Decision Analysis Framework on Respiratory Inhalers: Is It Always Useful in the MOH Malaysia Medicines Formulary Listing Context?
    Yong YV; Mahamad Dom SH; Ahmad Sa'ad N; Lajis R; Md Yusof FA; Abdul Rahaman JA
    MDM Policy Pract; 2021; 6(1):2381468321994063. PubMed ID: 33855190
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.
    Luiza VL; Chaves LA; Silva RM; Emmerick IC; Chaves GC; Fonseca de Araújo SC; Moraes EL; Oxman AD
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD007017. PubMed ID: 25966337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical monograph for drug formulary review: erectile dysfunction agents.
    Campbell HE
    J Manag Care Pharm; 2005 Mar; 11(2):151-71. PubMed ID: 15766322
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.